Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

79 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Essential role of the posterior morphogen nanos for germline development in Drosophila.
Kobayashi S, Yamada M, Asaoka M, Kitamura T. Kobayashi S, et al. Among authors: asaoka m. Nature. 1996 Apr 25;380(6576):708-11. doi: 10.1038/380708a0. Nature. 1996. PMID: 8614464
gone early, a novel germline factor, ensures the proper size of the stem cell precursor pool in the Drosophila ovary.
Matsuoka S, Gupta S, Suzuki E, Hiromi Y, Asaoka M. Matsuoka S, et al. Among authors: asaoka m. PLoS One. 2014 Nov 24;9(11):e113423. doi: 10.1371/journal.pone.0113423. eCollection 2014. PLoS One. 2014. PMID: 25420147 Free PMC article.
Germline stem cells in the Drosophila ovary descend from pole cells in the anterior region of the embryonic gonad.
Asaoka M, Lin H. Asaoka M, et al. Development. 2004 Oct;131(20):5079-89. doi: 10.1242/dev.01391. Development. 2004. PMID: 15459101
Maternal Nanos inhibits Importin-α2/Pendulin-dependent nuclear import to prevent somatic gene expression in the Drosophila germline.
Asaoka M, Hanyu-Nakamura K, Nakamura A, Kobayashi S. Asaoka M, et al. PLoS Genet. 2019 May 15;15(5):e1008090. doi: 10.1371/journal.pgen.1008090. eCollection 2019 May. PLoS Genet. 2019. PMID: 31091233 Free PMC article.
Maternal Nanos regulates zygotic gene expression in germline progenitors of Drosophila melanogaster.
Asaoka M, Sano H, Obara Y, Kobayashi S. Asaoka M, et al. Mech Dev. 1998 Nov;78(1-2):153-8. doi: 10.1016/s0925-4773(98)00164-6. Mech Dev. 1998. PMID: 9858716
Egfr signaling controls the size of the stem cell precursor pool in the Drosophila ovary.
Matsuoka S, Hiromi Y, Asaoka M. Matsuoka S, et al. Among authors: asaoka m. Mech Dev. 2013 Apr-May;130(4-5):241-53. doi: 10.1016/j.mod.2013.01.002. Epub 2013 Jan 31. Mech Dev. 2013. PMID: 23376160
Should we target "intermediate expression" of HER2 in older estrogen receptor positive patients?
Tokumaru Y, Le L, Asaoka M, Futamura M, Ishikawa T, Yoshida K, Takabe K. Tokumaru Y, et al. Among authors: asaoka m. Transl Cancer Res. 2020 Jul;9(7):4056-4059. doi: 10.21037/tcr-20-2231. Transl Cancer Res. 2020. PMID: 33102162 Free PMC article. No abstract available.
Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Oshi M, Asaoka M, Tokumaru Y, Angarita FA, Yan L, Matsuyama R, Zsiros E, Ishikawa T, Endo I, Takabe K. Oshi M, et al. Among authors: asaoka m. Cancers (Basel). 2020 Oct 19;12(10):3038. doi: 10.3390/cancers12103038. Cancers (Basel). 2020. PMID: 33086518 Free PMC article.
M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer.
Oshi M, Tokumaru Y, Asaoka M, Yan L, Satyananda V, Matsuyama R, Matsuhashi N, Futamura M, Ishikawa T, Yoshida K, Endo I, Takabe K. Oshi M, et al. Among authors: asaoka m. Sci Rep. 2020 Oct 6;10(1):16554. doi: 10.1038/s41598-020-73624-w. Sci Rep. 2020. PMID: 33024179 Free PMC article.
CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer.
Oshi M, Asaoka M, Tokumaru Y, Yan L, Matsuyama R, Ishikawa T, Endo I, Takabe K. Oshi M, et al. Among authors: asaoka m. Int J Mol Sci. 2020 Sep 22;21(18):6968. doi: 10.3390/ijms21186968. Int J Mol Sci. 2020. PMID: 32971948 Free PMC article.
79 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback